ScholarIQanswers from OpenAlex

Economic Burden of Patients with Diffuse Large B-cell and Follicular Lymphoma Treated in the USA

PaperCitations, authors & open-access status

Economic Burden of Patients with Diffuse Large B-cell and Follicular Lymphoma Treated in the USA is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Economic Burden of Patients with Diffuse Large B-cell and Follicular Lymphoma Treated in the USA have?

ScholarIQcitation count

Economic Burden of Patients with Diffuse Large B-cell and Follicular Lymphoma Treated in the USA has 47 citations in the OpenAlex counts ScholarIQ stores.

When was Economic Burden of Patients with Diffuse Large B-cell and Follicular Lymphoma Treated in the USA published?

ScholarIQyear

Economic Burden of Patients with Diffuse Large B-cell and Follicular Lymphoma Treated in the USA has 2018 year in the ScholarIQ index.

What is the open-access status of Economic Burden of Patients with Diffuse Large B-cell and Follicular Lymphoma Treated in the USA?

ScholarIQoa status

Economic Burden of Patients with Diffuse Large B-cell and Follicular Lymphoma Treated in the USA has hybrid oa status in the ScholarIQ index.

What is the DOI of Economic Burden of Patients with Diffuse Large B-cell and Follicular Lymphoma Treated in the USA?

ScholarIQdoi

The DOI for Economic Burden of Patients with Diffuse Large B-cell and Follicular Lymphoma Treated in the USA is on the source record.

What is the PMID of Economic Burden of Patients with Diffuse Large B-cell and Follicular Lymphoma Treated in the USA?

ScholarIQpmid

The PMID for Economic Burden of Patients with Diffuse Large B-cell and Follicular Lymphoma Treated in the USA is on the source record.

What is the OpenAlex record for Economic Burden of Patients with Diffuse Large B-cell and Follicular Lymphoma Treated in the USA?

ScholarIQopenalex

The OpenAlex for Economic Burden of Patients with Diffuse Large B-cell and Follicular Lymphoma Treated in the USA is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial